Publisher Continues Its Fight Against Price Surveys

The New York-based scientific publisher Gordon and Breach has suffered a setback in the first round of its legal battle waged in European courts against the American Institute of Physics. The publishing firm had brought suits against AIP last year, claiming that an article in the July 1988 issue of the institute's monthly, Physics Today, reporting on a survey of journal prices (The Scientist, Sept. 4, 1989, page 4), was damaging to Gordon and Breach. The article, written by retired physicist He

Written byKen Kalfus
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The New York-based scientific publisher Gordon and Breach has suffered a setback in the first round of its legal battle waged in European courts against the American Institute of Physics. The publishing firm had brought suits against AIP last year, claiming that an article in the July 1988 issue of the institute's monthly, Physics Today, reporting on a survey of journal prices (The Scientist, Sept. 4, 1989, page 4), was damaging to Gordon and Breach. The article, written by retired physicist Henry Barschall, reported that journals published by Gordon and Breach were significantly more expensive than those of other publishers.

In the suit in Zurich commercial court, the publisher charged that AIP and the American Physical Society, a member organization, had engaged in unfair comparative advertising. The case was dismissed on jurisdictional grounds from commercial court in Zurich on December 19, and Gordon and Breach was ordered to pay nearly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies